Results 171 to 180 of about 588,485 (325)
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Low-grade appendiceal mucinous tumor complicated by intussusception. [PDF]
Guo C, Qu Y, Liu H.
europepmc +1 more source
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin+10 more
wiley +1 more source
Staging of oral cavity cancer in the 8th edition of the TNM classification: The role of computed tomography in the assessment of depth of invasion and extranodal extension. [PDF]
Franceschi L+7 more
europepmc +1 more source
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern+7 more
wiley +1 more source
Beyond the expected: MRI features of a primary retro-uterine neuroendocrine tumor: A case report. [PDF]
Ezzoulali Z+10 more
europepmc +1 more source